Blog

Jul 09, 2023

Prevalence of anemia and associated factors among adult hypertensive patients in Referral Hospitals, Amhara Regional State

Scientific Reports volume 13, Article number: 14329 (2023) Cite this article Metrics details Anemia is a risk factor for adverse cardiovascular disease outcomes in hypertensive patients. Chronic

Scientific Reports volume 13, Article number: 14329 (2023) Cite this article

Metrics details

Anemia is a risk factor for adverse cardiovascular disease outcomes in hypertensive patients. Chronic anemia increases preload, reduces afterload, and leads to increased cardiac output in hypertension patients. In the long term, this may result in maladaptive left ventricular hypertrophy, which in turn is a well-recognized risk factor for cardiovascular disease outcomes and all-cause mortality in hypertension. Low hemoglobin and hematocrit levels might be strongly indicate hypertensive end-organ damage, specifically kidney failure. Therefore, this study determined the prevalence of anemia and associated factors among hypertensive patients in Referral Hospitals, Amhara Regional State, Ethiopia, in 2020. An institution-based cross-sectional study was conducted in Amhara Regional Referral Hospitals from February 20 to April 30, 2020. Random and systemic sampling techniques were used to select 428 study participants. Data were entered and coded in to Epi data version 3.0 and then exported into STATA 14 for analysis. In bivariable logistic regression, variables with a p-value of < 0.25 were included in multivariable logistic regression. Using a 95% confidence interval, variables having a p-value ≤ 0.05 in multivariable logistic regression were declared as statistically significant variables. In this study, a total of 428 study participants were involved with 99.5% response rate. The prevalence of anemia among hypertensive patients was 17.6%, with a 95% CI (14.3–21.5%). Estimated glomerular filtration rate (eGFR) < 90 ml/min (AOR = 2.77, 95% CI 1.56- 4.92)], duration of hypertension (HTN) ≥ 5 years (AOR = 2.37, 95% CI 1.36–4.15), uncontrolled blood pressure (AOR = 1.91, 95% CI 1.08–3.35), and higher pulse pressure (AOR = 1.05 (95% CI 1.02–1.08) were significantly associated with anemia. Nearly one out of five hypertensive patients had anemia. Impaired estimated glomerular filtration rate, duration of HTN, blood pressure status, and pulse pressure were the independent predictors of anemia among hypertensive patients. Screening hemoglobin level at a regular interval is recommended for the hypertensive patients to take an appropriate intervention.

Hypertension is a systolic blood pressure of 140 mm Hg or greater and/or a diastolic pressure of 90 mm Hg or greater in subjects who are not taking antihypertensive medication1. Every year, raised blood pressure kills nine million people2. The prevalence of hypertension ranges from 17 to 40% in developed countries and almost two-thirds of patients have untreated and poorly controlled hypertension3, 4. A systematic meta-analysis in Ethiopia showed that the prevalence of hypertension was 19.6%5.

Generally, non-communicable diseases (NCDs) are the major cause of death in the world. In 2008, NCDs accounted for more than 36 million (63%) of the 57 million deaths5. High blood pressure (BP) is the major risk factor for cardiovascular diseases and chronic kidney disease, and a leading cause of mortality world-wide6.

There is endothelial dysfunction in hypertensive patients, which is manifested by increased levels of vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), and von Willebrand Factor (vWF) in mediating vessel injury in hypertension, which leads to high levels of circulating pro-inflammatory cytokines7,8,9.

Pro-inflammatory cytokines, such as tumor necrosis factor and interleukin-6, have direct inhibitory effects on the bone marrow, which may cause anemia in hypertensive patients4, 10. Hypertension also strongly affects the functional and physicochemical properties of red blood cells (RBCs). Studies have shown that circulating RBCs might be impaired in hypertensive patients due to alterations in sodium–lithium counter-transport and sodium–potassium ATPase activity of RBC membranes11, 12. RBC deformability decreases due to sodium–potassium ATPase activity of RBC membrane impairment10, 12.

Anemia is a risk factor for adverse cardiovascular disease outcomes in hypertension13, 14. Low hemoglobin levels are associated with high risk of coronary heart disease13. Chronic anemia increase preload, reduces afterload, and leads to increased cardiac output in hypertension patients15. In the long term, this may result in maladaptive left ventricular hypertrophy, which in turn is a well-recognized risk factor for cardiovascular disease outcomes and all-cause mortality in hypertension15, 16. Recently, low hemoglobin and hematocrit levels strongly indicate hypertensive end-organ damage, specifically kidney failure in hypertensive patients17, 18.

However, there is limited information concerning the prevalence of anemia among hypertensive patients in Ethiopia. Therefore, this study aimed to assess the prevalence of anemia and associated factors among hypertensive patients in Amhara Regional State.

An institution-based cross-sectional study was conducted in selected referral hospitals, Amhara Regional State from February 2020 to April 30, 2020.

All adult hypertensive patients having follow-up at the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals were included in the study.

All patients with diabetic mellitus, chronic kidney disease, human immunodeficiency virus infection, and hematological malignancies were excluded from the study.

The sample size was calculated using a single population proportion formula based on estimates of 50% anemia prevalence, 95% confidence interval, and a 5% marginal error.

N: sample size, p: estimated prevalence value (50%), d: Margin of sampling error tolerated (5%), Zα/2 (1.96): critical value at 95% confidence interval of certainty.

After adding 11% of the non-response rate, a total of 428 participants were selected.

There were five referral hospitals in Amhara Region during our data collection period. Of those, the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals were selected using lottery methods of simple random sampling techniques.

Three hundred fifty and four hundred fifty hypertensive patients were encountered at the follow-up clinics of the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals, respectively, at the time of the data collection period. Using a systematic random sampling technique, 188 and 240 HTN patients were selected from the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals, respectively, with a K value of 2. The first patient was chosen by a lottery system, and then each of the first patients was interviewed (Fig. 1).

A flow chart describes the proportion of patients taking from the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals, 2020.

This research was carried out in accordance with the Helsinki Declaration's standards. The University of Gondar Institutional Review Board provided ethical clearance. Each study participant signed a written informed consent before the data collection began. For study participants who were unable to read or write, their parents or legally authorized representatives signed a written informed consent on their behalf. The privacy and confidentiality of study participant data were also carefully maintained.

Hypertension: a systolic blood pressure of 140 mmHg and/or a diastolic blood pressure of 90 mmHg (22) or who is taking antihypertensive medication1.

Anemia: a hemoglobin level less than 13 gm/dl in men and below 12 gm/dl in women for age ≥ 18 years old, as recommended by World Health Organization19.

Female participants with a blood hemoglobin level of (11–11.9 gm/dl), (8–10.9 gm/dl), and < 8 gm/dl have mild, moderate, and severe anemia respectively, whereas for male participants blood hemoglobin levels of (11–12.9 gm/dl), (8–10.9 gm/dl), and < 8 gm/dl have mild, moderate, and severe anemia, respectively19.

Impaired glomerular filtration rate: Patients who had an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 using EPI equations20,21,22.

Participants with a blood pressure of < 130/80 mmHg for at least three consecutive follow-up measurements were considered to have controlled blood pressure23.

Participants with a body mass index (BMI) of (< 18.5 kg/m2), (18.5–24.9 kg/m2), (25–29.9 kg/m2) where classified as underweight, normal, and overweight respectively, while BMI of ≥ 30 kg/m2 classified as obesity24, 25.

The data was collected using an interviewer-administered structured questionnaire that included socio-demographic information, medical card review, and weight and height assessment. Aside from the face-to-face interview, follow-up blood pressure records and patient cards were examined. The estimated glomerular filtration rate was calculated using the 2021 CKD-EPI creatinine equation, which is currently recommended for predicting GFR in adults 18 and older26, 27. The most recent creatinine and hemoglobin levels recorded in the medical record within one month prior to the time of data collection were taken.

A digital automatic blood pressure monitor was used to take blood pressure readings. Body weight and height were determined using a height measurement stand and a weighing machine. The participants' blood pressure, height, and weight were assessed according to established protocol, using World Health Organization protocol28.

After the data collected it were checked for its completeness, entered and coded in to Epi data version 3.0 and then exported to STATA 14 for analysis. Continuous variables were presented using mean and standard deviation, while for categorical variables like frequency and pie chart, were used.

The researchers used bivariable and multivariable logistic regression analyses. Variables associated with anemia with a p-value less than 0.25 using bi-variable logistic regression were included in the multivariable regression model. Finally, factors with a p-value of 0.05 or less in multivariable logistic regression were validated as significantly associated with anemia using a 95 percent confidence interval. The Hosmer and Lemeshow goodness test has been done to evaluate model fitness, and the value was 0.245.

To assure the data quality, training was given by the principal investigator to the data collectors with regard to the questioners, and the methods of data extraction from the patients’ charts. Four BSc nurses, working in a chronic follow up ward participated in the data collection process. The questionnaire, after being translated into Amharic by a language expert, was retranslated back into English by another expert for the consistency of the questionnaire. A pretest was conducted in Tibebe Ghion Specialized Hospital, and then the questionnaire was amended accordingly.

The data collectors were supervised by a supervisor and the principal investigator during the data collection period. To prevent coronavirus disease 2019 (COVID-19) transmission, the data collectors collect the data by applying the recommended COVID-19 prevention mechanisms.

A total of 428 hypertensive patients were participated in this study, and 99.5% (426) had respond to the survey. The majority of the study participants were 286 (67.1%) male sex, 349 (81.9%) married, 345 (81%) urban dwellers, and 165 (38.7%) had attained primary school (Table 1). The mean (± SD) age and body mass index of the study participants were (52.5 ± 16.8) years and (21.9 ± 2.7) kg/m2, respectively.

Most of the patients, 271 (64%) had been living with the disease for less than 5 years and had a mean creatinine of 1.1 mg/dl. The majority of the patients had 257 (60.3%) controlled blood pressure. The mean (± SD) systolic, and diastolic blood pressure of study participants were 119 ± 10.9 mg/dl, and 74.9 ± 7.7 mmHg, respectively (Table 2).

The mean hemoglobin level of the study participants was 12.7 gm/dl (SD ± 1.5). The prevalence of anemia was 17.6%, with 95% CI (14.3%-21.5%) among hypertensive patients. Among anemic hypertensive patients, the majority of the hypertensive patients had mild anemia 64 (51.2%) (Fig. 2).

Prevalence of anemia among hypertensive patients at the University of Gondar Comprehensive Specialized and Felege Hiwot Referral Hospitals in 2020.

In bivariable logistic regression, estimated glomerular filtration, age, income level, marital status, duration of the disease, educational level, blood pressure status, and pulse pressure were variables associated with anemia at p value < 0.25.

In the multivariable logistic regression, estimated glomerular filtration rate, duration of the disease, blood pressure status, and pulse pressure were variables associated with anemia.

Those patients with uncontrolled blood pressure were 1.91 (AOR = 1.91, 95% CI 1.08–3.35) times more likely to develop anemia as compared to those patients who had controlled blood pressure.

A one-unit increase in the pulse pressure of study participants led to a 1.05 fold (AOR = 1.05 (95% CI 1.02–1.08) increase in the odds of developing anemia.

The odds of having anemia was 2.37 (AOR = 2.37, 95% CI 1.36–4.15) times higher for those patients who had been living with the disease for ≥ 5 years as compared to less than 5 years.

Hypertensive patients with eGFR < 90 ml/min were 2.77 times (AOR = 2.77, 95% CI 1.56–4.92)] more likely to develop anemia than those patients having eGFR ≥ 90 ml/min (Table 3).

Hypertension is a major health problem worldwide and it is associated with an increased risk of cardiovascular disease. Even though hypertension has an impact on red blood cells, which increases the risk of cardiovascular complications, there is a scarcity of data pertaining to the prevalence of anemia among hypertensive patients. Therefore, to fill this gap this study aimed to determine the prevalence of anemia and associated factors among hypertensive patients.

The prevalence of anemia was 17.6% (95% CI 14.3–21.5%) among hypertensive patients. This result was similar to the study conducted in Australia (16%)4. But less than a study done in the USA (28%)29. This might be due to the sociodemographic difference in which the mean age of our study participants was lower. As age increase, the probability of being anemic increased30.

The pathophysiology of anemia in hypertensive patients can be explained in a variety of ways. Patients suffering from essential hypertension showed decreased deformability of red blood cells (RBC)11, 31. In hypertensive patients, there is a high intracellular concentration of sodium in red blood cells. This is due to impaired Na–K+ ATPase activity in hypertensive patients11. Again, hypertensive erythrocytes demonstrate membrane lipid peroxidation and reduced anti-oxidative enzyme activities, which expose the cell membrane to oxidative stress31. Therefore, those factors exposed the hypertensive patients’ RBC for hemolytic anemia. Endothelial dysfunction is another common phenomenon in hypertension that promotes the production of pro-inflammatory cytokines, which can lead to the suppression of erythropoiesis and resistance of the bone marrow to erythropoietin stimulation4, 32, 33. A high level of circulatory inflammatory cytokines such as tumor necrosis factor and interleukin-6 has a direct inhibitory effect on iron absorption from the gut and iron release from store cells via the hepcidin-mediated pathway, resulting in anemia34.

The majority of studies found a link between antihypertensive medication and anemia. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are antihypertensive medications that most commonly affect erythropoiesis process35.

Those patients with uncontrolled blood pressure were 1.91 times more likely to develop anemia as compared to those patients who had controlled blood pressure. This finding is in line with the other studies4, 15, 36, 37. As blood pressure increases, there is an increment in blood viscosity, the decrease in red blood cell (RBC) deformability, the formation of RBC rouleaux and RBC aggregates, which might result hemolysis of red blood cells33, 38.

A one-unit increase in hypertensive patients' pulse pressure (PP) resulted in a 1.1 fold increase in the odds of developing anemia, which is consistent with other studies15, 39. Studies showed, a high level of PP (> 80 mmHg) is strongly associated with arterial stiffness and can act as an independent risk factor for cardiovascular complications. This again suggests the necessity of close monitoring of anemia treatment39. Cardiovascular mortality significantly and regularly increases with increasing PP40. The mechanism for the relationship between anemia and PP remains unclear. However, there are previous studies that shows anemia was positively associated with a high PP. It associated positively with systolic blood pressure (SBP), but was inversely associated with diastolic blood pressure (DBP). Anemia also positively associated with arterial stiffness15, 41. Arterial stiffness is common presentation as pulse pressure increase15. One of the reasons is that SBP increased with a decrease in hemoglobin and hemoglobin but DBP decreased with a reduction in hemoglobin and hematocrits15, 33.

The odds of having anemia was 2.37 times more for those patients who had been living with the disease ≥ 5 years as compared to less than 5 years, in line with another study33, 42. Hypertensive patients with eGFR < 90 ml/min were 2.77 times more likely to develop anemia than those patients having eGFR ≥ 90 ml/min. Impaired glomerular filtration rate might be associated to anemia due to decreasing erythropoietin synthesis by the kidney. Studies showed that in essential hypertension there is mild renal insufficiency which might be linked to anemia43, 44. This renal impairment leads to anemia though compromised production of erythropoietin by peritubular fibroblast of the kidney45. As glomerular filtration rate decrease, renin angiotensin aldosterone system activated which increases the blood volume thereby causes haemodilution anemia in hypertensive patients33.

Low hemoglobin levels are associated with increased morbidity and mortality in hypertensive patients4, 46. In general, hypertensive patients' microcirculation is worsened and hypertensive complications are increased due to decreased red cell deformability and red blood cell membrane damage. The findings of this study are useful for better treatment with respect to minimizing the risk of complications developing in hypertensive patients.

As a result, hypertensive patients should have their hemoglobin levels checked on a regular basis to avoid end-organ damage.

In this investigation, glomerular filtration rate could be influenced by temporary changes in creatinine levels caused by a variety of variables that cannot be ruled out. Because only a single serum creatinine level in the medical record was used to compute the patients' eGFR. Since secondary data was used for the levels of hemoglobin and creatinine, it might affect the reliability of the data. The morphology of red blood cells was not included in this study, which is recommended for other researchers to study with a stronger study design to explore the cause-and-effect relationship between anemia and hypertension.

Nearly one out of five hypertensive patients had anemia. Most of the patients had mild anemia. Impaired estimated glomerular filtration rate, duration of HTN, blood pressure status, and pulse pressure were the independent predictors of anemia among hypertensive patients.

It is recommended that hypertensive patients have their hemoglobin levels checked at regular intervals in order to receive appropriate treatment and prevent hypertension-related complications.

The data will be available upon request from the corresponding author.

Diastolic blood pressure

Estimated glomerular filtration rate

Epidemiology collaboration

Hypertension

Pulse pressure

Non-communicable diseases

Red blood cell

Systolic blood pressure

WHO. Standard Treatment Guidelines: Hypertension Armed Forces. (2007).

Haldar, R. N. Global brief on hypertension: Silent killer, global public health crisis. Indian J. Phys. Med. Rehabil. 24, 2–2 (2013).

Article Google Scholar

Petrella, R. J., Merikle, E. P., Jones, J. & Plan, N. S. of Hypertension in Primary Care: Gaps, trends, and opportunities. 9, (2007).

Paul, B., Wilfred, N. C., Woodman, R. & DePasquale, C. Prevalence and correlates of anaemia in essential hypertension. Clin. Exp. Pharmacol. Physiol. 35, 1461–1464 (2008).

CAS PubMed Google Scholar

Kibret, K. T. & Mesfin, Y. M. Prevalence of hypertension in Ethiopia: A systematic meta-analysis. Public Health Rev. https://doi.org/10.1186/s40985-015-0014-z (2015).

Article PubMed PubMed Central Google Scholar

Jobe, M., Agbla, S. C., Prentice, A. M. & Hennig, B. J. High blood pressure and associated risk factors as indicator of preclinical hypertension in rural West Africa: A focus on children and adolescents in The Gambia. Med. (United States) 96, (2017).

Preston, R. A. et al. Effects of severe, uncontrolled hypertension on endothelial activation: Soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand Factor. J. Hypertens. 20, 871–877 (2002).

Article CAS PubMed Google Scholar

De Caterina, R. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17, 2646–2654 (1997).

Article PubMed Google Scholar

Xiao, L. & Harrison, D. G. Inflammation in hypertension. Can. J. Cardiol. 36, 635–647 (2020).

Article PubMed Google Scholar

Odashiro, K. et al. Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: Investigation by a nickel mesh filtration technique. Clin. Hypertens. 21, 1–8 (2015).

Article Google Scholar

Radosinska, J. & Vrbjar, N. The role of red blood cell deformability and Na, K-atpase function in selected risk factors of cardiovascular diseases in humans: Focus on hypertension, diabetes mellitus and hypercholesterolemia. Physiol. Res. 65, S43–S54 (2016).

Article PubMed Google Scholar

Tsuda, K. Red blood cell abnormalities and hypertension. Hypertens. Res. 43, 72–73 (2020).

Article PubMed Google Scholar

Chonchol, M. & Nielson, C. Hemoglobin levels and coronary artery disease. Am. Heart J. 155, 494–498 (2008).

Article CAS PubMed Google Scholar

Vlagopoulos, P. T. et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: The impact of chronic kidney disease. J. Am. Soc. Nephrol. 16, 3403–3410 (2005).

Article PubMed Google Scholar

Yoon, H. et al. The relationship between anemia and pulse pressure and hypertension: The Korea National Health and Nutrition Examination Survey 2010–2012. Clin. Exp. Hypertens. 40, 650–655 (2018).

Article PubMed Google Scholar

Elhendy, A. et al. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J. Am. Coll. Cardiol. 41, 129–135 (2003).

Article PubMed Google Scholar

Merad-boudia, H. N., Dali-Sahi, M., Kachekouche, Y. & Dennouni-Medjati, N. Hematologic disorders during essential hypertension. Diabetes Metab. Syndr. Clin. Res. Rev. 13, 1575–1579 (2019).

Article Google Scholar

Karabulut, A. Clinical implication of hematological indices in the essential hypertension. World J. Hypertens. 5, 93 (2015).

Article Google Scholar

Who & Chan, M. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switz. World Heal. Organ. 1–6 (2011).

Levey, A. S., Inker, L. A. & Coresh, J. Narrative review GFR estimation: From physiology to public health. Am. J. Kidney Dis. 63, 820–834 (2014).

Article PubMed PubMed Central Google Scholar

Hogg, R. J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 111, 1416–1421 (2003).

Article PubMed Google Scholar

Cockcroft, D. W. & Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–41 (1976).

Article CAS PubMed Google Scholar

Bahrey, D. et al. Prevalence and associated factors of chronic kidney disease among adult hypertensive patients in Tigray teaching hospitals: A cross-sectional study. BMC Res. Notes 12, 562 (2019).

Article PubMed PubMed Central Google Scholar

Anderson, A. K. Prevalence of anemia, overweight/obesity, and undiagnosed hypertension and diabetes among residents of selected communities in Ghana. Int. J. Chronic Dis. 2017, 1–7 (2017).

Article ADS Google Scholar

Tianyi, F. L., Agbor, V. N., Njamnshi, A. K. & Atashili, J. Factors associated with the prevalence of cognitive impairment in a rural elderly Cameroonian population: A community-based study in Sub-Saharan Africa. Dement. Geriatr. Cogn. 47, 104–113 (2019).

Article Google Scholar

Project, J. GFR estimates.

Milik, A. & Hrynkiewicz, E. KDIGO2012 clinical practice guideline for the evaluation and management of chronic kidney disease. IFAC Proc. 19, 4477–4483 (2014).

Google Scholar

WHO. World Health Organisation|Physical Measurements Overview Physical Measurements. World Heal. Organ. 1–16 (2017).

Gandhi, S. J., Hagans, I., Nathan, K., Hunter, K. & Roy, S. Prevalence, comorbidity and investigation of anemia in the primary care office. J. Clin. Med. Res. 9, 970–980 (2017).

Article PubMed PubMed Central Google Scholar

Fortún Prieto, A., Gort Cuba, O. & Campo Díaz, M. C. Causes of anemia and relationship of hemoglobin levels with age in a geriatric population. Rev. Ciencias Médicas Pinar del Río 22, 689–696 (2018).

Odashiro, K. et al. Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: Investigation by a nickel mesh filtration technique. Clin. Hypertens. 21, (2015).

Savoia, C. & Schiffrin, E. L. Inhibition of the renin angiotensin system: Implications for the endothelium. Curr. Diab. Rep. 6, 274–278 (2006).

Article CAS PubMed Google Scholar

Rabi, D. & Ashok, V. A Study of Hematological Parameters and Anthropometric Indicators in Hypertensive and Normotensive Males. Int. J. Curr. Res. Rev. 8, 06–12 (2016).

Google Scholar

Akchurin, O. et al. Interleukin-6 contributes to the development of anemia in Juvenile CKD. Kidney Int. Rep. 4, 470–483 (2019).

Article PubMed Google Scholar

Derman, W. Antihypertensive medications and exercise. Int. Sport. J. 9, (2008).

Erhabor, O., Shehu, A., Erhabor, T., Adias, T. C. & Iwueke, I. P. Some full blood count parameters among hypertensive patients attending specialist hospital, Sokoto Nigeria. Open J. Blood Dis. 09, 77–91 (2019).

Article CAS Google Scholar

Alemu, B., Techane, T., Dinegde, N. G. & Tsige, Y. Prevalence of anemia and its associated factors among chronic kidney disease patients attending selected public hospitals of Addis Ababa, Ethiopia: Institutional-based cross-sectional study. Int. J. Nephrol. Renovasc. Dis. 14, 67–75 (2021).

Article PubMed PubMed Central Google Scholar

Lee, C. A. & Paeng, D. G. Numerical simulation of spatiotemporal red blood cell aggregation under sinusoidal pulsatile flow. Sci. Rep. 11, 1–13 (2021).

Google Scholar

Ghosh, T., Rehman, T. & Ahamed, F. Relationship between hemoglobin and blood pressure levels in the context of chronic morbidity among older adults residing in a developing country: A community-level comparative cross-sectional study. Cureus 13, (2021).

Casiglia, E., Tikhonoff, V., Mazza, A. & Pessina, A. C. Systolic and pulse hypertension. Aging Health 1, 85–94 (2005).

Article Google Scholar

Tanaka, K. et al. Arterial stiffness is an independent risk factor for anemia after percutaneous native kidney biopsy. Kidney Blood Press. Res. 42, 284–293 (2017).

Article CAS PubMed Google Scholar

Li, N., Zhou, H. & Tang, Q. Red blood cell distribution width: A novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis. Markers 2017 (2017).

Jie, K. E. et al. Erythropoietin and the cardiorenal syndrome: Cellular mechanisms on the cardiorenal connectors. Am. J. Physiol. Ren. Physiol. 291, 932–945 (2006).

Article Google Scholar

Perticone, F., Maio, R., Tripepi, G. & Zoccali, C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 110, 821–825 (2004).

Article CAS PubMed Google Scholar

Taderegew, M. M., Gebremariam, T., Tareke, A. A., Garedew, G. & Woldeamanuel. Anemia and its associated factors among type 2 diabetes mellitus patients attending debre berhan referral hospital, north-east Ethiopia: A cross-sectional study. J. Blood Med. 11, 47–58 (2020).

Zakai, N. A. et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: The cardiovascular health study. Arch. Intern. Med. 165, 2214–2220 (2005).

Article PubMed Google Scholar

Download references

We would like to acknowledge the study participants, data collectors, and supervisors for their limitless collaboration during data collection. We are grateful to thank the University of Gondar for providing financial assistance for the study.

Department of Physiology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Yibeltal Yismaw Gela, Dagmawi Chilot & Mengistie Diress

Department of Human Anatomy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Daniel Gashaneh Belay & Anteneh Ayelign Kibret

Department of Anesthesia, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia

Amare Agmas Andualem

Department of Reproductive Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Desalegn Anmut Bitew

Department of Epidemiology and Biostatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Daniel Gashaneh Belay

Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia

Dagmawi Chilot

Department of Biomedical Science, Debre Markos University, Debre Markos, Ethiopia

Deresse Sinamaw

Department of Health Promotion and Health Behavior, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, PO.Box.196, Gondar, Ethiopia

Habitu Birhan Eshetu

Department of Clinical Pharmacy, School of Pharmacy, University of Gondar, Gondar, Ethiopia

Abdulwase Mohammed Seid

Department of Social and Administrative Pharmacy, School of Pharmacy, University of Gondar, Gondar, Ethiopia

Wudneh Simegn

Unit of Human Physiology, Department of Biomedical Science, College of Health Sciences, Debre Tabor University, Debra Tabor, Ethiopia

Mohammed Abdu Seid

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

You can also search for this author in PubMed Google Scholar

Y.Y.G. did the conceptualization, design of the work, methodology, analysis, data interpretation, and writing of the final manuscript. D.G.B., D.C., A.A.A., D.A.B., H.B.E., D.S., A.M.S., W.S., A.A.K., M.A.S. and M.D. contributed to the methodology, data analysis, interpretation, manuscript drafting, and substantive revisions. All authors agreed to accept responsibility for all aspects of the work and read and confirmed the final manuscript to be submitted to the current journal.

Correspondence to Yibeltal Yismaw Gela.

The authors declare no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

Gela, Y.Y., Belay, D.G., Chilot, D. et al. Prevalence of anemia and associated factors among adult hypertensive patients in Referral Hospitals, Amhara Regional State. Sci Rep 13, 14329 (2023). https://doi.org/10.1038/s41598-023-41553-z

Download citation

Received: 02 June 2022

Accepted: 28 August 2023

Published: 31 August 2023

DOI: https://doi.org/10.1038/s41598-023-41553-z

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.